Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
Group 1 – Carriers:
- People who have been confirmed to carry a gene change (variant) known to be linked to a higher risk of prostate cancer
- People who are having a prostate biopsy as part of prostate cancer screening, or who are having a biopsy or prostate removal surgery because they have been diagnosed with prostate cancer
Group 2 – Controls:
- People who are having a prostate biopsy as part of prostate cancer screening, or who are having a biopsy or prostate removal surgery because they have been diagnosed with prostate cancer
Who may not be able to join:
- No exclusion criteria have been listed for this trial (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kara N Maxwell, MD, PhD, University of Pennsylvania
Phone: 215-898-9698
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical and pathological data for patients with prostate tissue samples
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.